A review on the efficacy and safety of lipid-lowering drugs in neurodegenerative disease
Article in Reviews in the Neurosciences (April 2023)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
On the immunoregulatory role of statins in multiple sclerosis: the effects on Th17 cells
Article in Immunologic Research (August 2019)
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial
Article in PLOS ONE (January 2014)